Rene Hymel
Podiatrist · Metairie, LANPI 1871930305
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $411 and has fallen 78.3% since, to $89 in 2025. That places this record below the midpoint for podiatrist clinicians in LA, where the typical reported total is $2,398.
Across 26 payments — averaging $40.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$229
- Smith+Nephew$161
- Cerapedics Inc.$144
- Pacira Pharmaceuticals Incorporated$115
- Stryker$74
- ALON Medical Technology$69
- plus $252 from 7 others
What the payments were for
- Food & beverage$1,045100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 3 | $229 |
| Smith+Nephew | 3 | $161 |
| Cerapedics Inc. | 1 | $144 |
| Pacira Pharmaceuticals Incorporated | 1 | $115 |
| Stryker | 3 | $74 |
| ALON Medical Technology | 1 | $69 |
| Paratek Pharmaceuticals, Inc. | 4 | $69 |
| Nevro Corp. | 3 | $51 |
| Advanced Oxygen Therapy Inc. | 3 | $40 |
| Baxter Healthcare | 1 | $32 |
| Amgen | 1 | $25 |
| IBSA Pharma Inc. | 1 | $23 |
| KCI USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$144
- Santyl$122
- REGRANEX$122
- Oasis$122
- EXPAREL$115
How this compares
$1,045 in reported general payments places this provider in the 40th percentile of 68 podiatrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 109 | $3,107 |
| Diclofenac Sodium | 19 | $1,178 |
| Ketoconazole | 43 | $1,130 |
| Meloxicam | 220 | $491 |
| Allopurinol | 19 | $289 |
| Celecoxib | 32 | $262 |
| Clindamycin Hcl | 15 | $210 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Metairie
- Rory PanepintoMetairie$12K
- John CarradineMetairie$11K
- Robert MarroquinMetairie$9K
- Danielle RichardMetairie$7K
- Amber PoirotMetairie$3K
- Dorothy FulmerMetairie$1K
- Diamond BrownMetairie$939
- Cynthia BhattiMetairie$325
- Brian SchmidtMetairie$165
- Celia StoreyMetairie$121
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.